Search research articles
Contact Us
Filters
Showing results (11-20 of 104) with videos related to
Page
of 11
Sort By:
Clinics in Chest Medicine
|
May 28, 2016
Dysglycemia and Glucose Control During Sepsis
Mark P Plummer, Adam M Deane
Current Opinion in Critical Care
|
March 28, 2026
Glucagon-like peptide-1 drugs, gastrointestinal function and critical illness
Aniket Nadkarni, Adam M Deane, Mark P Plummer
Current Opinion in Clinical Nutrition and Metabolic Care
|
July 5, 2022
Is it time to personalise glucose targets during critical illness?
Mark P Plummer, Jeroen Hermanides, Adam M Deane
Critical Care Medicine
|
November 16, 2023
Apples and Oranges-All 'Vitamin C' May Not Be Created Equal
Mark P Plummer, Yugeesh R Lankadeva, Rinaldo Bellomo
Critical Care Clinics
|
February 21, 2019
Incretin Physiology and Pharmacology in the Intensive Care Unit
Mark P Plummer, Jeroen Hermanides, Adam M Deane
British Journal of Anaesthesia
|
January 29, 2026
Reversal of cerebral ischaemia and hypoxia and of sickness behaviour by megadose sodium ascorbate in ovine Gram-negative sepsis. Response to Br J Anaesth 2026; 136: 781-2
Clive N May, Mark P Plummer, Yugeesh R Lankadeva
Current Opinion in Critical Care
|
July 7, 2022
Update on glucose control during and after critical illness
Adam M Deane, Mark P Plummer, Yasmine Ali Abdelhamid
Critical Care (London, England)
|
July 17, 2014
Stress ulceration: prevalence, pathology and association with adverse outcomes
Mark P Plummer, Annika Reintam Blaser, Adam M Deane
Critical Care (London, England)
|
July 11, 2013
The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?
Mark P Plummer, Juris J Meier, Adam M Deane
Current Opinion in Critical Care
|
March 12, 2019
Gut dysmotility in the ICU: diagnosis and therapeutic options
Mark P Plummer, Annika Reintam Blaser, Adam M Deane
Page
of 11
Search research articles
Search
Showing results (11-20 of 104) with videos related to
Sort By:
Page
of 11
Clinics in Chest Medicine
|
May 28, 2016
Dysglycemia and Glucose Control During Sepsis
Mark P Plummer, Adam M Deane
Current Opinion in Critical Care
|
March 28, 2026
Glucagon-like peptide-1 drugs, gastrointestinal function and critical illness
Aniket Nadkarni, Adam M Deane, Mark P Plummer
Current Opinion in Clinical Nutrition and Metabolic Care
|
July 5, 2022
Is it time to personalise glucose targets during critical illness?
Mark P Plummer, Jeroen Hermanides, Adam M Deane
Critical Care Medicine
|
November 16, 2023
Apples and Oranges-All 'Vitamin C' May Not Be Created Equal
Mark P Plummer, Yugeesh R Lankadeva, Rinaldo Bellomo
Critical Care Clinics
|
February 21, 2019
Incretin Physiology and Pharmacology in the Intensive Care Unit
Mark P Plummer, Jeroen Hermanides, Adam M Deane
British Journal of Anaesthesia
|
January 29, 2026
Reversal of cerebral ischaemia and hypoxia and of sickness behaviour by megadose sodium ascorbate in ovine Gram-negative sepsis. Response to Br J Anaesth 2026; 136: 781-2
Clive N May, Mark P Plummer, Yugeesh R Lankadeva
Current Opinion in Critical Care
|
July 7, 2022
Update on glucose control during and after critical illness
Adam M Deane, Mark P Plummer, Yasmine Ali Abdelhamid
Critical Care (London, England)
|
July 17, 2014
Stress ulceration: prevalence, pathology and association with adverse outcomes
Mark P Plummer, Annika Reintam Blaser, Adam M Deane
Critical Care (London, England)
|
July 11, 2013
The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?
Mark P Plummer, Juris J Meier, Adam M Deane
Current Opinion in Critical Care
|
March 12, 2019
Gut dysmotility in the ICU: diagnosis and therapeutic options
Mark P Plummer, Annika Reintam Blaser, Adam M Deane
Page
of 11